15-26647529-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000311550.10(GABRB3):​c.241-25995A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.248 in 152,142 control chromosomes in the GnomAD database, including 5,934 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.25 ( 5934 hom., cov: 33)

Consequence

GABRB3
ENST00000311550.10 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0110

Publications

10 publications found
Variant links:
Genes affected
GABRB3 (HGNC:4083): (gamma-aminobutyric acid type A receptor subunit beta3) This gene encodes a member of the ligand-gated ionic channel family. The encoded protein is one the subunits of a multi-subunit chloride channel that serves as the receptor for gamma-aminobutyric acid, a major inhibitory neurotransmitter of the mammalian nervous system. This gene is located on the long arm of chromosome 15 in a cluster with two other genes encoding related subunits of the family. This gene may be associated with the pathogenesis of several disorders including Angelman syndrome, Prader-Willi syndrome, nonsyndromic orofacial clefts, epilepsy and autism. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Jul 2013]
GABRB3 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 43
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • epilepsy, childhood absence, susceptibility to, 5
    Inheritance: AD, Unknown Classification: DEFINITIVE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.801 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000311550.10. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRB3
NM_000814.6
MANE Select
c.241-25995A>G
intron
N/ANP_000805.1
GABRB3
NM_021912.5
c.241-25995A>G
intron
N/ANP_068712.1
GABRB3
NM_001191320.2
c.-15-25995A>G
intron
N/ANP_001178249.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRB3
ENST00000311550.10
TSL:1 MANE Select
c.241-25995A>G
intron
N/AENSP00000308725.5
GABRB3
ENST00000541819.6
TSL:1
c.409-25995A>G
intron
N/AENSP00000442408.2
GABRB3
ENST00000299267.9
TSL:1
c.241-25995A>G
intron
N/AENSP00000299267.4

Frequencies

GnomAD3 genomes
AF:
0.248
AC:
37669
AN:
152024
Hom.:
5922
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.279
Gnomad AMI
AF:
0.147
Gnomad AMR
AF:
0.312
Gnomad ASJ
AF:
0.178
Gnomad EAS
AF:
0.822
Gnomad SAS
AF:
0.412
Gnomad FIN
AF:
0.190
Gnomad MID
AF:
0.171
Gnomad NFE
AF:
0.173
Gnomad OTH
AF:
0.258
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.248
AC:
37727
AN:
152142
Hom.:
5934
Cov.:
33
AF XY:
0.255
AC XY:
18999
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.279
AC:
11571
AN:
41492
American (AMR)
AF:
0.313
AC:
4774
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.178
AC:
616
AN:
3470
East Asian (EAS)
AF:
0.821
AC:
4240
AN:
5162
South Asian (SAS)
AF:
0.412
AC:
1988
AN:
4824
European-Finnish (FIN)
AF:
0.190
AC:
2018
AN:
10600
Middle Eastern (MID)
AF:
0.187
AC:
55
AN:
294
European-Non Finnish (NFE)
AF:
0.173
AC:
11788
AN:
68006
Other (OTH)
AF:
0.257
AC:
543
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1339
2679
4018
5358
6697
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
396
792
1188
1584
1980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.210
Hom.:
13575
Bravo
AF:
0.264
Asia WGS
AF:
0.560
AC:
1950
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
5.7
DANN
Benign
0.70
PhyloP100
-0.011
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1863459; hg19: chr15-26892676; COSMIC: COSV54685500; API